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To the Editor:
The October 2014 issue (Vol. 9, 
no. 10) contained two articles about 
the management of “oligometastatic 
disease” which need comment. The 
first is a “concise review” of the role of 
stereotactic ablative radiotherapy in the 
management of pulmonary oligome-
tastases and oligometastatic disease.1 
A review published in a respected peer 
review journal should give some indica-
tion of how the evidence was identified, 
appraised, and used. In this case, there 
was no information on methods and it 
would appear that no systematic search 
was carried out as papers questioning 
the value of pulmonary metastasectomy 
were not cited. Although the issue of 
selection bias in the current literature, 
which is composed entirely of retrospec-
tive case series, was briefly discussed in 
the introduction, later when discussing 
“Future Trials and Conclusion,” selec-
tion bias was referred to as a “specter.” 
This implies that it is a ghostly illusion 
that needs exorcising, not a very real 
limitation to the available evidence.
Address for correspondence: Fergus Macbeth, 
DM, FRCR, FRCP, Wales Cancer Trials Unit, 
Cardiff University, Cardiff, UK. E-mail: fer-
gus.macbeth@btinternet.com
Disclosure: The authors declare no conflict of interest.
DOI: 10.1097/JTO.0000000000000454 
Copyright © 2015 by the International Association 
for the Study of Lung Cancer
ISSN: 1556-0864/15/1003-0e13
To the Editor:
Recently, we are interested to read 
the article by Tan et al.1 regarding the 
prognostic significance of lymph node 
ratio (LNR) in patients with esophageal 
cancer. The authors conclude that the 
LNR is an independent prognostic factor 
and prognosticates long-term outcomes 
of esophageal cancer after tri-incisional 
esophagectomy. We appreciated the 
authors on their excellent study, but we 
have some comments regarding their 
conclusions. First, we are puzzled about 
the authors’ conclusion that the number 
of LN metastasis is not an independent 
prognostic factor. Most of the studies2,3 
have shown that the number of LN metas-
tasis is an independent prognostic factor 
in esophageal cancer patients after esoph-
agectomy. We observed that the number 
of metastatic LNs was significantly cor-
related to that of retrieved LNs in the 
authors’ article. And our experience also 
suggests the number of metastatic LNs is 
closely related to the number of stations 
of metastatic LNs. If there is strong cor-
relation between variables in cox model, 
estimation of cox model parameters will 
be affected, and some variables affect-
ing prognosis will be excluded from the 
model for multi-collinearity.4 So principal 
components analysis or r-type clustering 
analysis should be used to eliminate the 
influence of multi-collinearity.4 However, 
authors’ inclusion of factors with close 
correlation in multivariate analysis, with-
out statistical adjustment, comes to con-
clusion that the number of LN metastasis 
is not an independent prognostic factor. 
Second, patients with the number of 
retrieved LNs less than 15 accounted for 
53.7% (376 of 700), which means LNs 
dissection in more than half of patients 
is insufficient. The authors’ results that 
higher LNR indicates poor prognosis can 
be explained that insufficient LNs dissec-
tion can miss occult metastatic LNs which 
lead to stage migration and overestimat-
ing the patients’ prognosis. Third, we find 
the numbers of patients with stage N2 and 
N3 are only 69 and 28, respectively, which 
makes few patients included in subgroup 
analysis. As Table 4 of the authors’ article 
shows, the number of patients with stage 
N2 and N3 in T1 and T2 subgroup is 
too small to achieve sufficient statistical 
power. We think it is not sufficient to draw 
the conclusion by authors that no signifi-
cant survival difference is observed in 
pN categories stratified by tumor status. 
Therefore, we should stick to the point 
that LNR is still not enough to replace 
the pN categories based on metastatic LN 
counts in the tumor-node metastasis clas-
sification system for esophageal cancer.
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